September 20

Familial Hypercholesterolaemia (FH) is a common genetic disorder associated with premature cardiovascular disease. Many people have FH and do not know it, and will perhaps not know it until they suffer a premature heart attack. There is a global need to initiate programmes to find and treat persons with FH. The tools are there to be used, the costs are low relative to the number of lives saved, and the potential health benefits are huge.

September 24 is FH-awareness day. All this week, in a series of newsletters, EAS highlights activities that are putting FH on the public health agenda. In this newsletter, we look at how EAS-FH Studies Collaboration is addressing scientific and organisational aspects of management of FH patients in Central & Eastern Europe.

EAS-FHSC Central & Eastern European Symposium on FH

EAS initiative – FH Studies Collaboration – organises together with local representatives the EAS-FHSC Central & Eastern European Symposium on FH, November 25-27, 2016 in Warsaw, Poland.

We have prepared an exciting agenda for the Symposium, of interest to physicians, researchers and others involved in the screening, diagnosis and management of patients with familial hypercholesterolaemia. The format will be a blend of lectures, workshops and lively discussions to stimulate exchange of knowledge and experience, both at a scientific and organizational levels. We are delighted that some of the most prominent experts working in the field will join us as faculty members.

The Symposium will also bring together leaders in the field with particular focus on the region of Central and Eastern Europe, in the Central & Eastern European Key Opinion Leader Summit.

For more information, follow these links to the Symposium Programme, confirmed faculty, practical information, and online registration.

Bringing together established researchers and clinicians working in the field of familial hypercholesterolaemia from the entire European region will enable us to discuss common problems and design future mutual projects. For the first time we will enjoy the opportunity to compare and evaluate the situation from different European countries. In particular we welcome countries in central and Eastern Europe into the global EAS-FHSC registry, which aims to provide the largest most contemporary data on FH prevalence, detection, management and consequences thereof.

Register now! The organizers look forward to welcoming you and your colleagues to Warsaw - the perfect setting to fulfil our mutual goals, to improve identification and provide better treatment for FH patients.

Read more about the meeting and register >>

Directly to the programme >>

Find out more

About this email


European Atherosclerosis Society © 2015

This email was sent to '@@email@@' from European Atherosclerosis Society.
If you wish to stop receiving email from us, you can simply remove yourself by visiting: @@unsubscribe_url@@